Market open· · ZAc · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Despite a decline in operating profit, Dis-Chem Pharmacies Ltd (JSE:DCP) showcases robust revenue growth and strategic advancements in digital transformation and market share expansion.
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Dis-Chem Pharmacies' (JSE:DCP) stock up by 9.1% over the past three months. Given that the market rewards strong...
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But in our...
Dis-Chem Pharmacies Limited ( JSE:DCP ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is...
Dis-Chem Pharmacies Ltd (JSE:DCP) reports robust revenue and profitability growth, driven by new store openings and strategic investments, despite challenges in financing and inventory management.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.